CAUTION #2: the screen may benefit from a sustained earnings growth filter. Several of the companies are one-hit wonders; CV vaccine grant biotech speculation, one-time windfall, &c.

The addition of Revenue Growth (3 Yrs) Filter (best 3 of 6) excluded half of those included in "Consumer Discretionary Sector". And at a glance does appear to improve quality, which should be confirmed a backtest.

Sorted by :W/O Revenue 3y  Sector       Industry                Sub-Industry  PP (13w)
Count Sectors                       61
Consumer Discretionary     Health Care  Information Technology
                       12           14                      35

Sorted by : W/ Revenue 3y  Sector       Industry                Sub-Industry  RS (13w,52w)
Count Sectors                       49                                        
Consumer Discretionary     Health Care  Information Technology                
                        6           12                      31

Criteria:
 
Positive Earnings Surprises (90 Days)
20.16% and Above
839
Revenue Growth (TTM vs. Prior TTM)
15.57% and Above
209
Volume (30 Day Average)
0.65 and Above
117
Sector/Industry/Sub-Industry
Consumer Discretionary, Health Care, Information Technology selected
74
Market Capitalization
$692.95M and Above
61
Security Type
Common Stock
56
Revenue Growth (3 Yrs)
9.02% and Above
49
Price Performance (13 Weeks)
None selected
49
Price Performance (52 Weeks)
None selected
49

GD